| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $2.5M | 0.00% | 266.50K | −15% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a DHC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Portnoy Adam DDirector | Stock Award(Grant) at price 0.00 per share. | 59.7K | — |
| Sep 9, 2026 | Brown Matthew C.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 53K | — |
| Sep 9, 2026 | Bilotto Christopher J.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 59.7K | — |
| Jun 9, 2026 | Portnoy Adam DDirector | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jun 9, 2026 | Somers Jeffrey PDirector | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jun 9, 2026 | Jones Lisa HarrisDirector | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jun 9, 2026 | Bilotto Christopher J.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jun 9, 2026 | Hollis Phyllis M.Director | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jun 9, 2026 | Neher Dawn K.Director | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Jun 9, 2026 | Felder Alan LDirector | Stock Award(Grant) at price 0.00 per share. | 12.4K | — |
| Dec 14, 2025 | Bilotto Christopher J.Chief Executive Officer | Purchase at price 4.89 per share. | 20K | $97.72K |
| Sep 8, 2025 | Portnoy Adam DDirector | Stock Award(Grant) at price 0.00 per share. | 81.8K | — |
| Sep 8, 2025 | Brown Matthew C.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 37.4K | — |
| Sep 8, 2025 | Bilotto Christopher J.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 81.8K | — |
| May 28, 2025 | Portnoy Adam DDirector | Stock Award(Grant) at price 0.00 per share. | 29.1K | — |
| May 28, 2025 | Somers Jeffrey PDirector | Stock Award(Grant) at price 0.00 per share. | 29.1K | — |
| May 28, 2025 | Jones Lisa HarrisDirector | Stock Award(Grant) at price 0.00 per share. | 29.1K | — |
| May 28, 2025 | Bilotto Christopher J.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 29.1K | — |
| May 28, 2025 | Hollis Phyllis M.Director | Stock Award(Grant) at price 0.00 per share. | 29.1K | — |
| May 28, 2025 | Neher Dawn K.Director | Stock Award(Grant) at price 0.00 per share. | 29.1K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 19.8 | 16.4 | -1.8 | 13.6 | 10.3 | 11.8 | -4.3 | -14.9 | 3.7 | -2.9 | +57.2% | ||
| 2025 | 7.8 | 14.1 | -15.2 | -5.8 | 38.5 | 14.4 | -8.7 | 16.5 | 15.7 | -3.4 | 13.4 | 0.4 | +110.9% |
| 2024 | -23.3 | 14.3 | -25.0 | -4.1 | 3.0 | 25.5 | 9.5 | 4.2 | 20.4 | -14.8 | -27.2 | -11.5 | −38.5% |
| 2023 | 21.5 | 24.1 | 37.8 | -32.6 | 49.5 | 65.4 | -7.1 | 30.1 | -28.7 | 6.7 | 13.0 | 59.8 | +475.4% |
| 2022 | -1.3 | -5.6 | 11.1 | -29.7 | 0.9 | -19.8 | -4.9 | -15.6 | -32.2 | 37.4 | -27.2 | -34.3 | −79.0% |
| 2021 | -2.4 | 11.9 | 6.2 | -7.5 | -17.9 | 15.2 | -6.7 | -3.8 | -9.6 | 7.4 | -23.4 | 10.8 | −25.0% |
| 2020 | -8.5 | -18.5 | -42.3 | -14.3 | 15.1 | 23.7 | -12.0 | -2.6 | -7.4 | -17.6 | 52.1 | -6.6 | −51.2% |
| 2019 | 17.5 | -6.0 | -9.0 | -31.8 | -1.9 | 4.9 | -0.8 | 3.5 | 9.1 | 7.2 | -26.3 | 15.3 | −28.0% |
| 2018 | -9.5 | -12.6 | 3.4 | -0.6 | 13.4 | 2.4 | -1.4 | 7.1 | -8.1 | -8.5 | -14.4 | -14.8 | −38.8% |
| 2017 | 0.6 | 7.6 | -1.2 | 6.3 | -1.8 | -3.3 | -4.8 | 1.4 | -0.9 | -5.9 | 4.1 | 0.0 | +1.2% |
| 2016 | -2.4 | 7.8 | 14.6 | -1.7 | 6.3 | 11.5 | 6.6 | 0.6 | 1.7 | -6.3 | -15.1 | 4.8 | +27.6% |
| 2015 | 5.3 | -4.0 | -0.7 | -7.8 | -2.2 | -12.3 | -1.6 | -9.1 | 3.2 | -6.2 | -4.9 | 3.6 | −32.3% |
| 2014 | 1.3 | -1.0 | 0.8 | 4.5 | 2.2 | 1.3 | -5.9 | 2.1 | -10.3 | 8.0 | -0.3 | -1.9 | −0.5% |
| 2013 | 1.9 | 4.2 | 6.9 | 6.0 | -9.1 | 0.3 | -3.0 | -9.5 | 2.6 | 5.6 | -8.1 | -1.9 | −6.0% |
| 2012 | 1.1 | -5.6 | 3.0 | 0.1 | -6.5 | 8.1 | 1.9 | -2.8 | -1.5 | 0.9 | 1.7 | 5.8 | +5.3% |
| 2011 | 2.2 | 9.5 | -6.1 | 3.0 | 1.8 | -3.1 | 2.3 | -0.6 | -9.5 | 4.2 | -2.4 | 2.4 | +2.3% |
| 2010 | -4.7 | -0.3 | 6.5 | 1.5 | -7.3 | -3.5 | 12.1 | 4.2 | 0.0 | 1.7 | -6.5 | -1.7 | +0.3% |
| 2009 | -9.7 | -22.0 | 11.1 | 16.9 | 2.2 | -2.6 | 14.3 | 7.5 | -4.7 | 0.9 | 7.7 | 5.3 | +22.0% |
| 2008 | -1.3 | -5.0 | 11.4 | 1.1 | -7.3 | -12.1 | 7.8 | 3.0 | 9.9 | -19.6 | -27.3 | 28.6 | −21.0% |
| 2007 | 6.3 | -8.0 | -0.2 | -4.5 | 2.9 | -13.4 | -15.1 | 17.7 | 8.5 | 1.6 | -1.5 | 2.7 | −7.4% |
Buy / hold / sell counts
Diversified Healthcare Trust is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC's portfolio is anchored by a strategically curated mix of senior housing, medical office and life science assets that combine high quality care, modern technology and amenity rich environments to meet rising demand across the healthcare continuum. As of June 30, 2026, DHC's approximately 6.3 billion dollar portfolio included 285 properties in 33 states and Washington, D.C., with 23,797 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group, a leading U.S. alternative asset management company with over 37 billion dollar in assets under management as of June 30, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, Massachusetts. Diversified Healthcare Trust was established in 1998 and is incorporated in Maryland.